Mike Zablocki
General Manager
Mike is General Manager of the Malaghan Institute, responsible for the corporate, commercial and support functions of the organisation. He is also a Director of Wellington Zhaotai Therapies Limited, a joint venture established by the Malaghan Institute to develop innovative cell therapies for the global market.
Mike completed a Bachelor of Arts at the University of Bristol, before moving to New Zealand in 2002 when he joined the Malaghan as a database administrator. In 2011 he completed his Postgraduate Diploma in Business Administration at Victoria University of Wellington. He was appointed as General Manager in 2016.
Malaghan Institute to collaborate with IARC/WHO to reduce global burden of stomach cancer
24 July 2026
Reading a tumour’s fingerprint for personalised immunotherapies
22 July 2026
Farewell to Graham Malaghan, steward of a family legacy
6 July 2026
The changing face of allergy treatment
24 June 2026
Breakthrough Malaghan and University of Auckland cancer research advances into new biotech venture
16 June 2026
HRC funding to improve CAR T-cell ‘fitness’ and better fight cancer
11 June 2026
Malaghan Institute to collaborate with IARC/WHO to reduce global burden of stomach cancer
24 July 2026
Reading a tumour’s fingerprint for personalised immunotherapies
22 July 2026
Farewell to Graham Malaghan, steward of a family legacy
6 July 2026
The changing face of allergy treatment
24 June 2026
Breakthrough Malaghan and University of Auckland cancer research advances into new biotech venture
16 June 2026
HRC funding to improve CAR T-cell ‘fitness’ and better fight cancer
11 June 2026